vs
Azenta, Inc.（AZTA）与CVD EQUIPMENT CORP（CVV）财务数据对比。点击上方公司名可切换其他公司
Azenta, Inc.的季度营收约是CVD EQUIPMENT CORP的30.0倍（$148.6M vs $5.0M）。Azenta, Inc.净利率更高（-10.4% vs -25.6%，领先15.2%）。Azenta, Inc.同比增速更快（0.8% vs -33.2%）。Azenta, Inc.自由现金流更多（$14.7M vs $396.0K）。过去两年Azenta, Inc.的营收复合增速更高（4.4% vs 0.3%）
Azenta成立于1978年，总部位于美国马萨诸塞州切姆斯福德，是全球知名的生命科学服务提供商，核心业务覆盖基因组学、低温存储、自动化解决方案及信息学服务，为生命科学领域研究及产业客户提供专业技术支持。
CVD Equipment Corp是一家专业设计、生产和供应定制化化学气相沉积系统、热处理设备及相关过程控制解决方案的企业，产品服务于半导体制造、可再生能源、航空航天、先进材料研发等领域，客户覆盖全球商用及科研机构。
AZTA vs CVV — 直观对比
营收规模更大
AZTA
是对方的30.0倍
$5.0M
营收增速更快
AZTA
高出34.0%
-33.2%
净利率更高
AZTA
高出15.2%
-25.6%
自由现金流更多
AZTA
多$14.3M
$396.0K
两年增速更快
AZTA
近两年复合增速
0.3%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $148.6M | $5.0M |
| 净利润 | $-15.4M | $-1.3M |
| 毛利率 | 42.9% | 22.2% |
| 营业利润率 | -4.9% | -27.2% |
| 净利率 | -10.4% | -25.6% |
| 营收同比 | 0.8% | -33.2% |
| 净利润同比 | -15.7% | -1060.6% |
| 每股收益（稀释后） | $-0.34 | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AZTACVV
| Q4 25 | $148.6M | $5.0M | ||
| Q3 25 | $159.2M | $7.4M | ||
| Q2 25 | $143.9M | $5.1M | ||
| Q1 25 | $143.3M | $8.3M | ||
| Q4 24 | $147.4M | $7.4M | ||
| Q3 24 | $150.6M | $8.2M | ||
| Q2 24 | $144.3M | $6.3M | ||
| Q1 24 | $136.4M | $4.9M |
净利润AZTACVV
| Q4 25 | $-15.4M | $-1.3M | ||
| Q3 25 | $50.9M | $384.0K | ||
| Q2 25 | $-48.0M | $-1.1M | ||
| Q1 25 | $-47.7M | $360.0K | ||
| Q4 24 | $-11.0M | $132.0K | ||
| Q3 24 | $-6.6M | $203.0K | ||
| Q2 24 | $-6.6M | $-761.0K | ||
| Q1 24 | $-137.4M | $-1.5M |
毛利率AZTACVV
| Q4 25 | 42.9% | 22.2% | ||
| Q3 25 | 45.4% | 32.7% | ||
| Q2 25 | 46.2% | 21.0% | ||
| Q1 25 | 43.8% | 32.4% | ||
| Q4 24 | 46.7% | 26.3% | ||
| Q3 24 | 45.5% | 21.5% | ||
| Q2 24 | 44.8% | 24.3% | ||
| Q1 24 | 43.8% | 16.2% |
营业利润率AZTACVV
| Q4 25 | -4.9% | -27.2% | ||
| Q3 25 | 1.2% | 4.2% | ||
| Q2 25 | -1.3% | -22.3% | ||
| Q1 25 | -12.7% | 3.2% | ||
| Q4 24 | -5.9% | 0.4% | ||
| Q3 24 | -3.1% | 0.9% | ||
| Q2 24 | -4.9% | -14.2% | ||
| Q1 24 | -18.1% | -33.0% |
净利率AZTACVV
| Q4 25 | -10.4% | -25.6% | ||
| Q3 25 | 32.0% | 5.2% | ||
| Q2 25 | -33.4% | -20.8% | ||
| Q1 25 | -33.3% | 4.3% | ||
| Q4 24 | -7.5% | 1.8% | ||
| Q3 24 | -4.4% | 2.5% | ||
| Q2 24 | -4.5% | -12.0% | ||
| Q1 24 | -100.8% | -29.9% |
每股收益（稀释后）AZTACVV
| Q4 25 | $-0.34 | $-0.19 | ||
| Q3 25 | $1.12 | $0.06 | ||
| Q2 25 | $-1.05 | $-0.15 | ||
| Q1 25 | $-1.04 | $0.05 | ||
| Q4 24 | $-0.25 | $0.02 | ||
| Q3 24 | $-0.25 | $0.03 | ||
| Q2 24 | $-0.12 | $-0.11 | ||
| Q1 24 | $-2.48 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $336.6M | $8.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.7B | $24.7M |
| 总资产 | $2.1B | $27.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AZTACVV
| Q4 25 | $336.6M | $8.7M | ||
| Q3 25 | $279.8M | $8.4M | ||
| Q2 25 | $270.0M | $7.0M | ||
| Q1 25 | $253.6M | $10.2M | ||
| Q4 24 | $377.5M | $12.6M | ||
| Q3 24 | $280.0M | $10.0M | ||
| Q2 24 | $336.5M | $10.0M | ||
| Q1 24 | $353.5M | $11.9M |
总债务AZTACVV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $268.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AZTACVV
| Q4 25 | $1.7B | $24.7M | ||
| Q3 25 | $1.7B | $25.8M | ||
| Q2 25 | $1.7B | $25.2M | ||
| Q1 25 | $1.7B | $26.0M | ||
| Q4 24 | $1.7B | $25.4M | ||
| Q3 24 | $1.8B | $25.0M | ||
| Q2 24 | $2.0B | $24.5M | ||
| Q1 24 | $2.2B | $25.0M |
总资产AZTACVV
| Q4 25 | $2.1B | $27.5M | ||
| Q3 25 | $2.1B | $29.8M | ||
| Q2 25 | $2.0B | $29.9M | ||
| Q1 25 | $2.0B | $31.1M | ||
| Q4 24 | $2.0B | $31.7M | ||
| Q3 24 | $2.1B | $31.8M | ||
| Q2 24 | $2.3B | $33.8M | ||
| Q1 24 | $2.6B | $35.4M |
负债/权益比AZTACVV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.8M | $397.0K |
| 自由现金流经营现金流 - 资本支出 | $14.7M | $396.0K |
| 自由现金流率自由现金流/营收 | 9.9% | 8.0% |
| 资本支出强度资本支出/营收 | 4.2% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $30.9M | — |
8季度趋势，按日历期对齐
经营现金流AZTACVV
| Q4 25 | $20.8M | $397.0K | ||
| Q3 25 | $2.2M | $1.4M | ||
| Q2 25 | $25.8M | $-3.2M | ||
| Q1 25 | $14.4M | $-2.3M | ||
| Q4 24 | $29.8M | $2.3M | ||
| Q3 24 | $17.7M | $32.0K | ||
| Q2 24 | $9.8M | $-1.7M | ||
| Q1 24 | $8.7M | $-2.0M |
自由现金流AZTACVV
| Q4 25 | $14.7M | $396.0K | ||
| Q3 25 | $-5.7M | — | ||
| Q2 25 | $15.0M | $-3.2M | ||
| Q1 25 | $7.0M | $-2.3M | ||
| Q4 24 | $22.0M | $2.1M | ||
| Q3 24 | $8.3M | $-5.0K | ||
| Q2 24 | $1.3M | $-1.8M | ||
| Q1 24 | $428.0K | $-2.1M |
自由现金流率AZTACVV
| Q4 25 | 9.9% | 8.0% | ||
| Q3 25 | -3.6% | — | ||
| Q2 25 | 10.4% | -62.1% | ||
| Q1 25 | 4.9% | -27.7% | ||
| Q4 24 | 15.0% | 28.8% | ||
| Q3 24 | 5.5% | -0.1% | ||
| Q2 24 | 0.9% | -29.0% | ||
| Q1 24 | 0.3% | -42.9% |
资本支出强度AZTACVV
| Q4 25 | 4.2% | 0.0% | ||
| Q3 25 | 4.9% | 0.0% | ||
| Q2 25 | 7.5% | 0.1% | ||
| Q1 25 | 5.2% | 0.5% | ||
| Q4 24 | 5.3% | 1.5% | ||
| Q3 24 | 6.2% | 0.5% | ||
| Q2 24 | 5.9% | 1.8% | ||
| Q1 24 | 6.1% | 1.4% |
现金转化率AZTACVV
| Q4 25 | — | — | ||
| Q3 25 | 0.04× | 3.53× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6.28× | ||
| Q4 24 | — | 17.05× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
CVV
| Transferred Over Time | $3.8M | 76% |
| Transferred At Point In Time | $1.2M | 24% |
